Compounds of formulae I and II: are disclosed as 5-HT.sub.3 inhibitors. Those compounds that exhibit central activity are useful in treating CINV; those that inhibit peripheral receptors are useful to treat IBS-D.

 
Web www.patentalert.com

< Kappa opioid receptor ligands

< Amide bridged piphenyl or biazaphenyl derivatives

> Methods of using thiazolidine derivatives to treat cancer or inflammation

> Aryl carbonyl derivatives as therapeutic agents
~ 00284